Bioneer Corporation (KOSDAQ:064550)

Market Cap	307.66B -24.8%
Revenue (ttm)	320.69B +11.5%
Net Income	-8.97B
EPS	-348.00
Shares Out	25.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,753
Average Volume	114,885
Open	11,820
Previous Close	11,820
Day's Range	11,820 - 12,230
52-Week Range	10,500 - 17,950
Beta	0.08
RSI	44.36
Earnings Date	Mar 25, 2026

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 367
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550

Financial Performance

In 2024, Bioneer's revenue was 293.98 billion, an increase of 11.68% compared to the previous year's 263.24 billion. Losses were -20.58 billion, 94.4% more than in 2023.